Indivior PLC Company Profile (LON:INDV)

About Indivior PLC (LON:INDV)

Indivior PLC logoIndivior PLC (Indivior) is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence (the Indivior Business). Its treatment and pipeline focus is opioid use disorder, alcohol use disorder, overdose rescue and central nervous system (CNS) disorders/schizophrenia. Its products are Suboxone Film (buprenorphine and naloxone), Suboxone Tablet (buprenorphine and naloxone), and Subutex Tablet (buprenorphine). Its other products include RBP-6000 in ATRIGEL, RBP-7000 risperidone monthly depot, Arbaclofen placarbil for alcohol use disorder (AUD), Intranasal naloxone for treatment of opioid overdose and RBP-8000 cocaine esterase for cocaine intoxication. Its RBP-6000 buprenorphine monthly depot is developed for the treatment of opioid use disorder. Its RBP-7000 risperidone monthly depot is developed for treatment of schizophrenia.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Specialty & Advanced Pharmaceuticals
  • Sub-Industry: N/A
  • Symbol: LON:INDV
  • CUSIP: N/A
  • Web:
  • Market Cap: £2.36 billion
  • Outstanding Shares: 720,988,000
Average Prices:
  • 50 Day Moving Avg: GBX 325.90
  • 200 Day Moving Avg: GBX 336.25
  • 52 Week Range: GBX 246.50 - GBX 421.50
  • Trailing P/E Ratio: 30.23
  • P/E Growth: -0.43
Sales & Book Value:
  • Annual Revenue: £1.08 billion
  • Price / Sales: 2.19
  • Book Value: GBX (0.18) per share
  • Price / Book: -18.21
  • EBITDA: £228 million
  • Net Margins: 25.35%
  • Return on Assets: 22.93%
  • Average Volume: 2.77 million shs.

Frequently Asked Questions for Indivior PLC (LON:INDV)

What is Indivior PLC's stock symbol?

Indivior PLC trades on the London Stock Exchange (LON) under the ticker symbol "INDV."

Where is Indivior PLC's stock going? Where will Indivior PLC's stock price be in 2017?

6 analysts have issued 1 year price targets for Indivior PLC's stock. Their forecasts range from GBX 280 to GBX 500. On average, they expect Indivior PLC's share price to reach GBX 400.50 in the next year. View Analyst Ratings for Indivior PLC.

Who are some of Indivior PLC's key competitors?

Who are Indivior PLC's key executives?

Indivior PLC's management team includes the folowing people:

  • Howard Pien, Executive Chairman of the Board
  • Shaun Thaxter, Chief Executive Officer, Executive Director
  • Mark Crossley, Chief Financial Officer, Executive Director
  • Jon Fogle, Chief Human Resource Officer
  • Ingo Elfering, Chief Information Officer
  • Christian Heidbreder, Chief Scientific Officer
  • Kathryn Hudson, Company Secretary
  • Tatjana May, Non-Executive Director
  • A. Thomas McLellan Ph.D., Non-Executive Director
  • Daniel Tasse, Senior Independent Director

How do I buy Indivior PLC stock?

Shares of Indivior PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Indivior PLC's stock price today?

One share of Indivior PLC stock can currently be purchased for approximately GBX 327.80.

MarketBeat Community Rating for Indivior PLC (LON INDV)
Community Ranking:  3.7 out of 5 (star star star)
Outperform Votes:  305 (Vote Outperform)
Underperform Votes:  104 (Vote Underperform)
Total Votes:  409
MarketBeat's community ratings are surveys of what our community members think about Indivior PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Indivior PLC (LON:INDV) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: GBX 400.50
Consensus Price Target History for Indivior PLC (LON:INDV)
Price Target History for Indivior PLC (LON:INDV)
Analysts' Ratings History for Indivior PLC (LON:INDV)
DateFirmActionRatingPrice TargetDetails
10/20/2017Numis Securities LtdReiterated RatingBuyGBX 500View Rating Details
9/15/2017Stifel NicolausReiterated RatingBuyGBX 400View Rating Details
9/8/2017Jefferies Group LLCLower Price TargetBuyGBX 540 -> GBX 358View Rating Details
9/5/2017Citigroup Inc.Reiterated RatingNeutralGBX 280View Rating Details
8/3/2017Royal Bank Of CanadaReiterated RatingOutperformGBX 470View Rating Details
2/23/2017Deutsche Bank AGReiterated RatingBuyGBX 395View Rating Details
8/1/2016Morgan StanleyBoost Price TargetOverweightGBX 280 -> GBX 330View Rating Details
(Data available from 10/20/2015 forward)


Earnings History for Indivior PLC (LON:INDV)
No earnings announcements for this company have been tracked by


Earnings Estimates for Indivior PLC (LON:INDV)
Current Year EPS Consensus Estimate: $0.38 EPS


Dividend History for Indivior PLC (LON:INDV)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Indivior PLC (LON:INDV)
Insider Trades by Quarter for Indivior PLC (LON:INDV)
Insider Trades by Quarter for Indivior PLC (LON:INDV)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/24/2017Lorna ParkerInsiderBuy1,231GBX 342£4,210.02
5/12/2016Tassé,DanielInsiderBuy3,903GBX 161£6,283.83
5/13/2015Daniel TasséInsiderBuy6,209GBX 229.28£14,236
3/27/2015Shaun ThaxterInsiderBuy20,000GBX 196£39,200
3/26/2015Shaun ThaxterInsiderBuy10,000GBX 197.17£19,717
2/16/2015Shaun ThaxterInsiderBuy35,000GBX 161.59£56,556.50
2/13/2015Cary ClaiborneInsiderBuy62,000GBX 166.24£103,068.80
2/12/2015Cary ClaiborneInsiderBuy23,780GBX 170£40,426
2/11/2015Shaun ThaxterInsiderBuy10,000GBX 163.36£16,336
(Data available from 1/1/2013 forward)


Headline Trends for Indivior PLC (LON:INDV)
Latest Headlines for Indivior PLC (LON:INDV)
DateHeadline logoIndivior PLC (INDV) Receives Consensus Rating of "Buy" from Brokerages - October 18 at 9:04 PM logoIndivior Submits NDA To FDA For RBP-7000, Signs Pact With Durect - October 2 at 1:11 PM logoIndivior files to sell schizophrenia drug in U.S. - October 2 at 1:11 PM logoIndivior PLC (INDV) Receives Average Rating of "Buy" from Analysts - September 23 at 6:54 PM logoWhy this beaten-up FTSE 100 dividend stock could be a bargain - September 17 at 6:58 PM logoIndivior Unit Files Lawsuits In U.S. To Protect SUBOXONE Film Patent - September 16 at 7:05 PM logoIndivior PLC's (INDV) Buy Rating Reiterated at Numis Securities Ltd - September 15 at 11:46 AM logoIndivior PLC (INDV) Stock Rating Reaffirmed by Stifel Nicolaus - September 15 at 11:46 AM logoIndivior PLC (INDV) Given New GBX 358 Price Target at Jefferies Group LLC - September 9 at 7:32 PM logoIndivior Plc – Value Analysis (LONDON:INDV) : September 7, 2017 - September 7 at 8:06 PM logoIndivior Plc breached its 50 day moving average in a Bearish Manner : INDV-GB : September 6, 2017 - September 6 at 6:27 AM logoIndivior PLC (INDV) Earns "Neutral" Rating from Citigroup Inc. - September 5 at 4:44 PM logoWhy I think Indivior plc is a growth stock for shrewd investors - September 4 at 11:50 PM logoWhy I’d avoid Indivior plc today after shares crash 35% - September 2 at 1:17 AM logoIndivior To Appeal Ruling To Defend Intellectual Property For Suboxone Film - September 2 at 1:17 AM logo[$$] Indivior: cold turkey - September 1 at 8:16 PM logo[$$] Indivior's shares plummet after defeat in patent battle - September 1 at 8:16 PM logoRBP Global Holdings Ltd -- Moody's: Patent ruling is credit negative for Indivior - September 1 at 8:16 PM logoIndivior plunges after court ruling on patents - MarketWatch - September 1 at 5:56 AM logoResults boost European shares, Indivior plunge puts pressure on UK mid caps - September 1 at 5:55 AM logoIndivior PLC (INDV) Receives Consensus Recommendation of "Buy" from Brokerages - August 29 at 6:36 PM logoInvestors Are Hooked on This Drugmaker Battling Opioid Abuse - August 8 at 7:32 PM logoIndivior PLC (LON:INDV) Given Average Rating of "Buy" by Brokerages - August 4 at 6:46 PM logoIndivior PLC Announces FDA Acceptance with Priority Review Designation of RBP-6000 Buprenorphine Monthly Depot ... - PR Newswire (press release) - August 1 at 8:31 PM logoIndivior PLC Announces FDA Acceptance with Priority Review Designation of RBP-6000 Buprenorphine Monthly Depot New Drug Application (NDA) for the Treatment of Opioid Use Disorder - July 31 at 7:16 PM logoIndivior's RBP-6000 drug gets FDA priority review - MarketWatch - July 31 at 4:24 AM logoIndivior PLC (INDV) Lifted to Outperform at Royal Bank Of Canada - July 29 at 10:35 PM logo2 value stocks to consider in an expensive market: Indivior plc and Impellam Group plc - July 27 at 10:40 PM logoIndivior raises yearly forecast - July 27 at 10:40 PM logoEdited Transcript of INDV.L earnings conference call or presentation 27-Jul-17 11:00am GMT - July 27 at 10:40 PM logoNumis Securities Ltd Reaffirms "Buy" Rating for Indivior PLC (LON:INDV) - July 27 at 11:21 AM logoIndivior PLC (INDV) Given Consensus Rating of "Buy" by Analysts - July 10 at 7:07 PM logoIndivior earnings rise, reiterates outlook - May 4 at 11:08 PM logoUK Stocks-Factors to watch on Feb. 22 - February 22 at 12:39 PM logoWill this spin-off stock continue to slay FTSE 100 giants? - February 22 at 12:39 PM logoUnilever, Lloyds help Britain's FTSE edge higher - February 22 at 12:39 PM


Social activity is not available for this stock.


Indivior PLC (INDV) Chart for Friday, October, 20, 2017

This page was last updated on 10/20/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.